ReadMax-a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild-type non-small-cell lung cancer.
Journal Information
Full Title: J Pathol Clin Res
Abbreviation: J Pathol Clin Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Joachim Moecks is a former employee of F. Hoffmann‐La Roche Ltd. Denis Soulières has participated in advisory boards for Genentech/Roche and has received honoraria for conference presentations unrelated to the subject of this paper. Barbara Klughammer is a current employee of F. Hoffmann‐La Roche Ltd and owns stock in the company."
Funding Disclosure
Evidence found in paper:
"Support for third‐party medical writing assistance was provided by F. Hoffmann‐La Roche Ltd."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025